Nonsteroidal Antiinflammatory Drugs or Acetaminophen for Osteoarthritis of the Hip or Knee? A Systematic Review of Evidence and Guidelines

Journal of Rheumatology

Volumn 31, Issue 2, 2004, Pages 344-354

  Wegman, Anke ^a,b   Van Der Windt, Daniëlle ^a,b,d   Van Tulder, Maurits ^a,b   Stalman, Wim ^a,b   De Vries, Theo ^a,c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Dept Clin Epidemiol/Biostatist ^*

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Guidelines; Metaanalysis practice; Nonsteroidal antiinflammatory agents; Osteoarthritis acetaminophen

Indexed keywords

COCODAMOL; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; FENOPROFEN; IBUPROFEN; KETOPROFEN; MISOPROSTOL; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; SALICYLIC ACID;

BIBLIOGRAPHIC DATABASE; CALCULATION; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISABILITY; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDICATION; EVIDENCE BASED MEDICINE; EXPECTATION; GASTROINTESTINAL TOXICITY; HIP OSTEOARTHRITIS; HUMAN; KNEE OSTEOARTHRITIS; MEDICAL LITERATURE; META ANALYSIS; NEPHROTOXICITY; OUTCOMES RESEARCH; PAIN; PATIENT EDUCATION; PATIENT INFORMATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SIDE EFFECT; STANDARDIZATION; TREATMENT OUTCOME;

ACETAMINOPHEN; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; EVIDENCE-BASED MEDICINE; HUMANS; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; PRACTICE GUIDELINES;

EID: 0742322753     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Lawrence RC, Helmick CG, Arnett FC, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998;41:778-99.
2. Van Saase JL, van Romunde LK, Cats A, Vandenbroucke JP, Valkenburg HA. Epidemiology of osteoarthritis: Zoetermeer survey. Comparison of radiological osteoarthritis in a Dutch population with that in 10 other populations. Ann Rheum Dis 1989;48:271-80.
3. Hochberg MC, Altman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part I. Osteoarthritis of the hip. Arthritis Rheum 1995;38:1535-40.
4. Hochberg MC, Altman RD, Brandt KD, et al. Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. Arthritis Rheum 1995;38:1541-6.
5. Holbrook AM, for the Ontario Musculoskeletal Therapy Review Panel. Medical treatment guidelines for the treatment of osteoarthritis, rheumatoid arthritis, and acute musculoskeletal injury. Toronto: Ontario Ministry of Health and Long-term Care; 2000.
6. Bierma-Zeinstra SM, Lipschart S, Njoo KH, et al. How do general practitioners manage hip problems in adults? Scand J Prim Health Care 2000;18:159-64.
7. Traynor V, Britt H, Neary S, Sayer GP, Charles J, Meza RA. The management of osteoarthritis in general practice. Results from the Australian Morbidity and Treatment Survey, 1990-1991. Aust Fam Phys 1994;23:1971-8.
8. Mamlin LA, Melfi CA, Parchman ML, et al. Management of osteoarthritis of the knee by primary care physicians. Arch Fam Med 1998;7:563-7.
9. Mazzucca SA, Brandt KD, Katz BP, et al. Comparison of general internists, family physicians, and rheumatologists managing patients with symptoms of osteoarthritis of the knee. Arthritis Care Res 1997;10:289-99.
10. Griffin M, Piper JM, Daugherty JR, Snowden M, Ray WA. Nonsteroidal anti-inflammatory drug use and increased risk of peptic ulcer disease in elderly persons. Ann Intern Med 1991;114:257-63.
11. Singh G, Rosen Ramey D. NSAID induced gastrointestinal complications: the ARAMIS perspective - 1997. J Rheumatol 1998;25 Suppl 51:8-16.
12. Henry D, Lim LL, Garcia Rodriguez LA, et al. Variability in the risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ 1996;312:1563-6.
13. Fored CM, Ejerblad E, Lindblad P, et al. Acetaminophen, aspirin, and chronic renal failure. N Engl J Med 2001;345:1801-8.
14. Whitcomb DC, Block GD. Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA 1994;272:1845-50.
15. Schiodt FV, Rochling FA, Casey DL, Lee WM. Acetaminophen toxicity in an urban county hospital. N Engl J Med 1997;337:1112-7.
16. Hylek EM, Heiman H, Skates SJ, Sheehan MA, Singer DE. Acetaminophen and other risk factors for excessive warfarin anticoagulation. JAMA 1998;279:657-62.
17. Scott DL. Guidelines for the diagnosis, investigation and management of osteoarthritis of the hip and knee. Report of a Joint Working Group of the British Society for Rheumatology and the Research Unit of the Royal College of Physicians. J Roy Coll Physicians Lond 1993;27:391-6.
18. Bijl D, Dirven-Meijer PC, Opstelten W, et al. NHG-standaard Niet-traumatische Knieproblemen bij volwassenen. [General practice guidelines for non-traumatic knee complaints in adults]. Huisarts & Wetenschap 1998;41:344-50.
19. Eccles M, Freemantle N, Mason J. North of England evidence based guideline development project: summary guideline for non-steroidal anti-inflammatory drugs versus basic analgesia in treating the pain of degenerative arthritis. BMJ 1998;317:526-30.
20. Williams HJ, Ward JR, Egger MJ, et al. Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee. Arthritis Rheum 1993;36:1196-206.
21. Bradley JD, Brandt KD, Katz BP, Kalasinki LA, Ryan SI. Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Engl J Med 1991;325:87-91.
22. American College of Rheumatology Subcommittee on osteoarthritis guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000;43:1905-15.
23. Puhl W, Bernau A, Böhle E, et al. Ambulatory diagnosis and therapy of gonarthrosis [German]. Z Orthop 2000;138:85-93.
24. Pendleton A, Arden N, Dougados M, et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2000;59:936-44.
25. Wolfe F, Zhao S, Lane N. Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients. Arthritis Rheum 2000;43:378-85.
26. Moskowitz RW. The role of anti-inflammatory drugs in the treatment of osteoarthritis: a United States viewpoint. Clin Exp Rheumatol 2001;19 Suppl 25:S3-8.
27. Hungin APS, Kean WF. Non-steroidal anti-inflammatory drugs: overused or underused in osteoarthritis? Am J Med 2001;110:8S-11S.
28. Jawad AS. EULAR recommendations for the management of knee osteoarthritis. Ann Rheum Dis 2001;60:540.
29. Felson DT. The verdict favors nonsteroidal antiinflammatory drugs for treatment of osteoarthritis and a plea for more evidence on other treatments. Arthritis Rheum 2001;44:1477-80.
30. Dieppe PA. Concerns about the methodology used in developing the 2000 update of the American College of Rheumatology recommendations for management of hip and knee osteoarthritis [letter]. Arthritis Rheum 2001;44:2450-1.
31. Brandt KD. A critique of the 2000 update of the American College of Rheumatology recommendations for management of osteoarthritis [letter]. Arthritis Rheum 2001;44:2451-5.
32. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. BMJ 1994;309:1286-91.
33. Van Tulder MW, Scholten RJ, Koes BW, Deyo RA. Nonsteroidal anti-inflammatory drugs for low back pain: a systematic review within the framework of the Cochrane Collaboration Back Review Group. Spine 2000;25:2501-13.
34. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. New Engl J Med 1988;318:1728-33.
35. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
36. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
37. Fleiss JL. The statistical basis of meta-analysis. Stat Methods Med Res 1993;2:121-45.
38. The AGREE Collaboration. Appraisal of Guidelines for Research and Evaluation (AGREE) Instrument. Available from: www.agreecollaboration.org [cited September 10, 2003].
39. Amadio P, Cummings DM. Evaluation of acetaminophen in the management of osteoarthritis of the knee. Curr Ther Res 1983;34:59-66.
40. Amor B, Benarrosh C. A method for comparing analgesics: glafenine and paracetamol multicenter cross-over approach. Clin Rheumatol 1988;7:492-7.
41. Finkbeiner G. Treatment of the diseases of the extended rheumatic sphere form with paracetamol [German]. Münch Med Wochenschr 1973;115:1855-7.
42. Kjaersgaard-Andersen P. Evaluating codeine plus paracetamol for pain. Nurs Times 1991;87:52.
43. Parr G, Darekar B, Fletcher A, Bulpitt CJ. Joint pain and quality of life; results of a randomised trial. Br J Clin Pharmacol 1989;27:235-42.
44. Brooks PM, Dougan MA, Mugford S, Meffin E. Comparative effectiveness of 5 analgesics in patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 1982;9:723-6.
45. Altman RD, for the IAP Study Group. Ibuprofen, acetaminophen, and placebo in osteoarthritis of the knee: a six-day double-blind study [abstract]. Arthritis Rheum 1999;42 Suppl:S403.
46. Pincus T, Koch CG, Sokka T, et al. A randomized-double blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee. Arthritis Rheum 2001;44:1587-98.
47. Bradley JD, Brandt KD, Katz BP, Kalasinski LA, Ryan SI. Treatment of knee osteoarthritis: relationship of clinical features of joint inflammation to the response to a nonsteroidal antiinflammatory drug or pure analgesic. J Rheumatol 1992;19:1950-4.
48. Bradley JD, Katz BP, Brandt KD. Severity of knee pain does not predict a better response to an antiinflammatory dose of ibuprofen than to analgesic therapy in patients with osteoarthritis. J Rheumatol 2001;28:1073-6.
49. Solomon L, Abrams G. Orudis in the management of osteoarthritis of the knee. A double-blind trial. S Afr Med J 1974;48:1526-9.
50. Wojtulewski JA, Hart FD, Huskisson EC. Fenoprofen in treatment of osteoarthritis of the hip and knee. BMJ 1974;2:475-6.
51. Eccles M, Freemantle N, Mason J. North of England Evidence Based Guidelines Development Project: methods of developing guidelines for efficient drug use in primary care. BMJ 1998;316:1232-5.
52. Geba GP, Weaver AL, Polis AB, Dixon ME, Schnitzer TJ. Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee - a randomized trial. JAMA 2002;287:64-71.
53. Case JP, Baliunas AJ, Block JA. Lack of efficacy of acetominophen in treating symptomatic knee osteoarthritis. Arch Intern Med 2003;163:169-78.
54. Cook DJ, Guyatt GH, Laupacis A, Sackett DL. Rules of evidence and-clinical recommendations on the use of antithrombotic agents. Chest 1992;102:305S-11S.
55. Dougados M, LeClaire P, Van der Heijde D, Bloch DA, Bellamy N, Altman RD. Response criteria for clinical trials on osteoarthritis of the knee and hip. Osteoarthritis Cartilage 2000;8:395-403.
56. Ehrich EW, Davies GM, Watson DJ, Bolognese JA, Seidenberg BC, Bellamy N. Minimal perceptible clinical improvement with the Western Ontario and McMaster Univeristies Osteoarthritis index questionnaire and global assessment in patients with osteoarthritis. J Rheumatol 2000;27:2635-41,
57. Scott-Lennox JA, McLaughlin-Miley C, Lennox RD, et al. Stratification of flare intensity identifies placebo responders in a treatment efficacy trial of patients with osteoarthritis. Arthritis Rheum 2001;44:1599-607.
58. Pincus T, Swaeringen C, Cummings P, Callahan LF. Preference for non-steroidal antiinflammatory drugs versus acetaminophen and concomitant use of both types of drugs in patients with osteoarthritis. J Rheumatol 2000;27:1020-7.
59. Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Developing guidelines. BMJ 1999;318:593-6.
60. Harbour R, Miller J. A new system for grading recommendations in evidence based guidelines. BMJ 2001;323:334-6.
61. Garcia Rodriguez LA, Hernandez-Diaz S. The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetominophen, and combinations of these agents. Arthritis Res 2001;3:98-101.
62. Rahme E, Pettitt D, LeLorier J. Determinants and sequelae associated with utilization of acetaminophen versus traditional nonsteroidal antiinflammatory drugs in an elderly population. Arthritis Rheum 2002;46:3046-54.
63. Courtney P, Doherty M. Key questions concerning acetaminophen and NSAIDs for osteoarthritis. Ann Rheum Dis 2002;61:767-73.
64. Dieppe P. From protocols to principles, from guidelines to toolboxes: aids to good management of osteoarthritis. Rheumatology Oxford 2001;40:841-2.
65. Edwards A, Elwyn G. Understanding risk and lessons for clinical risk communication about treatment preferences. Qual Health Care 2001;10 Suppl 1:9-13.
66. Elwyn G, Edwards A, Kinnersley P, Grol R. Shared decision making and the concept of equipoise: the competences of involving patients in healthcare choices. Br J Gen Pract 2000;50:892-9.
67. March L, Irwig L, Schwarz J, Simpson J, Chock C, Brooks P. N of 1 trials comparing a non-steroidal anti-inflammatory drug with paracetamol in osteoarthritis. BMJ 1994;309:1041-5.
68. Nikles CJ, Glasziou PP, Del Mar CB, Duggan CM, Clavarino A, Yelland MJ. Preliminary experiences with a single-patient trials service in general practice. Med J Aust 2000;173:100-3.